Riskpilot← Back to searchSign inGet full accessHAMAR DYREKLINIKK AS
ASActiveOrg 994288636Vangsvegen 132, 2318 HamarVeterinary activities · NACE 7500Est. 20095 employees
Revenue 2025
NOK 5,2M
-7% vs 2024
EBITDA margin
-6.6%
+12% vs 2024
Equity ratio
3.6%
Financial strength
Net profit 2025
NOK -184K
+57% vs 2024
| Revenue | NOK 5,2M | -7% |
| EBITDA | NOK -340K | +12% |
| Net profit | NOK -184K | +57% |
| Total assets | NOK 1,7M | +193% |
| Equity | NOK 63K | +110% |
| Employees | 5 | — |
Legal name
HAMAR DYREKLINIKK AS
Org number
994288636
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
4. juli 2009
Share capital
NOK 425 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Selskapets formål er å drive veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Vangsvegen 132, 2318 Hamar
Phone
+4762509100
Email
post@hamardyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 875 | 6 163 | 6 398 | 5 561 | 5 187 |
| Staff expenses | −3 144 | −3 232 | −3 634 | −3 363 | −2 966 |
| EBITDA | 106 | 191 | −228 | −389 | −340 |
| Depreciation & amort. | −153 | −148 | −104 | −37 | −11 |
| EBIT | −47 | 43 | −331 | −425 | −351 |
| Net financials | −5 | −2 | −2 | −2 | −45 |
| Profit before tax | −52 | 42 | −333 | −427 | −395 |
| Tax | −0 | −0 | −0 | −0 | −211 |
| Net profit | −52 | 42 | −333 | −427 | −184 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 907 | 957 | 703 | 597 | 1 747 |
| Equity | 66 | 108 | −225 | −652 | 63 |
| Long-term debt | 51 | 0 | 0 | 0 | 0 |
| Short-term debt | 790 | 849 | 928 | 1 249 | 1 684 |
| Total debt | 840 | 849 | 928 | 1 249 | 1 684 |
EBITDA margin
-6.6%
This company
15.8%
Market median
-142% vs market
20212025
Equity ratio
3.6%
This company
38.2%
Market median
-91% vs market
20212025
Return on equity
-290.6%
This company
18.4%
Market median
-1679% vs market
20212025
Net profit margin
-3.6%
This company
8.1%
Market median
-144% vs market
20212025
Asset turnover
2.97×
This company
1.12×
Market median
+165% vs market
20212025
Debt / equity
26.53×
This company
0.62×
Market median
-4179% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LT Chief Executive Officer | Chief Executive Officer | 2025 |
TE Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
HS Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2025 | |
| Chairman | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Empet Holding As
HAMAR DYREKLINIKK AS Board members of HAMAR DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helene Sofie Marvik | Chief Executive Officer | 0 companies |
| Lars Tessem | Chief Executive Officer | 0 companies |
| Tor Erik Reinås | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |
| Anne Øverby Øvergaard | Board of Directors | 0 companies |
| Christian Kolthoff | Chairman | 0 companies |